Today's Edition
ABU DHABI (WAM)
PureHealth, the largest healthcare platform in the Middle East, has recorded Dh1 billion on local procurement to support the National ICV Programme since the first quarter of 2023.
The programme is one of the cornerstones of the UAE’s national industrial strategy, which aims to raise the industrial sector’s contribution to the GDP to reach Dh300 billion by 2031.
PureHealth unveiled its progress towards its Dh13 billion target in local procurement by 2032 during the Make it in the Emirates Forum, being held at the Abu Dhabi Energy Centre on 27-28 May.
The milestone confirms that PureHealth is on track to achieving its target and highlights its central role in driving the UAE’s economic diversity.
Aligned with the nation’s vision for an economically self-sufficient and health-secure future, PureHealth is shaping a resilient and sustainable healthcare environment.
PureHealth remains a major national player and contributor to the UAE’s economic and social development, providing offtakes to support local healthcare manufacturing capabilities while creating local employment opportunities and delivering world-class health services.
Following an agreement with the Ministry of Industry and Advanced Technology (MoIAT) to join the National ICV Programme in 2022, PureHealth has made significant strides.
Initially committing Dh 10 billion to local procurement by 2032, the group, in 2023 increased this commitment by 30 percent to Dh13 billion.
In addition, PureHealth has effectively implemented ICV strategies across its operations, extending this effort in 2023 to include its subsidiaries, such as Abu Dhabi Health Services Company (SEHA), Rafed and Daman, thereby strengthening its ICV framework efforts.
In August 2023, SEHA achieved an ICV score of 79.1 percent, the highest among UAE healthcare companies, demonstrating PureHealth's leadership in the sector.
Daman, another PureHealth entity, also attained an impressive ICV score of 71.83 percent, giving it a competitive edge in the government procurement process.
These results underscore PureHealth's dedication to enhancing the industrial sector through strategic investments and partnerships with UAE-based suppliers.
Undersecretary of MoIAT, Omar Al Suwaidi, said, " The Ministry is proceeding, in light of the directives of the wise leadership and the strategic vision of the UAE, to promote the ICV Programme as part of the “Projects of the 50” of the UAE. This initiative plays a vital role in enhancing and empowering the growth and competitiveness of the industrial and advanced technology sectors, and supporting investors in the country, in line with the Ministry’s objectives to create an attractive environment for both local and international investment."
“The ICV Programme has witnessed significant growth in terms of size and impact since its launch, redirecting Dh 67 billion into the national economy in 2023. Purchasing opportunities were also expanded to include 1,400 products, and the total value of announced purchase agreements reached Dh120 billion. The third edition of the ‘Make in the Emirates Forum,’ held on May 27 and 28, saw further announcements and new purchasing opportunities. By directing additional resources from the government and private sector to the national economy, the ICV programme stimulates economic growth, thus enhancing investment attractiveness in the industrial sector, especially in priority industries such as health care,” he added.
Group CEO of PureHealth, Shaista Asif, said, “PureHealth is a committed member of the National ICV Programme in line with our support for the objectives of Operation 300bn as well as the UAE’s efforts to create a world-leading healthcare system."
